Protein–protein interaction analysis using the STRING database identified FGFR3, HRAS, and TP53 as central hubs in bladder cancer signaling, particularly within the MAPK and PI3K/AKT pathways [35, 36]. The gene discussed is HRAS; the disease is urinary bladder carcinoma.